These findings indicate that NFATc1 protein expression in pancreatic cancer cells decreases the potency of diverse anticancer agents, suggesting that NFATc1 plays a key role in modulating drug response in pancreatic cancer. The gene discussed is NFATC1; the disease is pancreatic neoplasm.